-
Pharmaceutical companies and clinical research institutions have adhered to drug safety regulations and standards for decades. But in recent years there has been a trend of increasing attention paid to pharmacovigilance, with drug safety staffs increasing rapidly at research institutions and clinical research organizations (CROs).
-
Clinical research sites in the process of revising tools or forms might find a new web site, funded by the National Institutes of Health (NIH) a useful place to begin the process.
-
-
Clinical trial sites and research institutions could save time and improve reporting efficiency by working with a drug safety group, experts say.
-
Clinical trial sites and CT coordinators increasingly feel pressure to fit more work into an already long day.
-
Although the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) is not as high in home care as it is in hospitals, the Centers for Disease Control and Prevention addresses the risk and identification of the infection as well as precautions to take to prevent spread of any antibiotic-resistant infection in non-hospital settings on its web site .
-
Antibiotic-resistant infections are not new to the health care setting, but headlines throughout the country have increased public awareness of the potential risk of infection.
-
Hospice professionals need to be aware that end-of-life patients sometimes are dealing with post-traumatic stress from previous traumas, whether they served in a war or were abused as children.
-
Past traumatic experiences can result in current physical, emotional, and behavioral symptoms among hospice patients.
-
